- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06821295
Efficacy of a Smartphone-Based JITAI to Reduce Drinking Among Adults Experiencing Homelessness (SmartT_A)
Efficacy of a Smartphone-Based Just-In-Time Adaptive Intervention to Reduce Drinking Among Adults Experiencing Homelessness
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The study will test the efficacy of a novel smartphone-based alcohol use reduction intervention (i.e., Smart-T Alcohol) relative to Usual Care in an RCT of heavy-drinking adults experiencing homelessness (N = 600). Participants will complete a screening visit on-site at one of our partnering shelters. Eligible participants will receive training in our smartphone-based assessment platform and may be provided with a compatible device if they do not own one. All participants will use the app to complete four brief (1-2 minute) daily EMAs for 1 week to obtain baseline drinking levels and psychosocial drinking risk factors (e.g., drinking urge, mood, alcohol availability, abstinence motivation). Individuals that complete at least 50% of the daily surveys will then be told if they were randomized to either standard shelter-based treatment (Usual Care; UC) or UC + Smart-T Alcohol intervention (1:1 allocation). The Smart-T Alcohol Intervention will last for eight weeks. An additional 4 weeks of EMA following treatment completion will be used to determine if intervention effects are maintained in the 4-weeks following the end of treatment. Follow-up assessments will occur via Insight(TM) app, at shelters, or via phone at end-of-treatment (i.e., 9 weeks post-enrollment), as well as 13- and 26-weeks post-enrollment. Participants in both groups will complete daily EMAs for a total of 13 weeks (see participant flow in Figure 2). Considering both established recommendations for treatment trials of AUDs and our emphasis on a harm reduction approach for this population, our primary efficacy outcome (Aim 1) will be total alcohol consumption, with # of drinking days and # of heavy drinking days serving as secondary outcomes. Given our preliminary study revealed EMA reports had substantially better agreement with objective markers of alcohol use compared to TLFB, EMA will be used to calculate primary and secondary outcomes. However, analyses will be repeated using TLFB-based outcomes (i.e., 9, 13, and 26-weeks) to facilitate direct comparisons to prior research and examine intervention effects. Additional analyses will examine intervention effects on key drinking risk factors per our conceptual framework (i.e., drinking urge, mood, alcohol availability, abstinence motivation) and whether these effects mediate treatment outcome (Aim 2), as well as subpopulations for whom the intervention may be more or less effective (e.g., women, younger adults, those with comorbid mental health or substance use problems, individuals engaging more heavily with shelter services; Exploratory Aim 3).
Interventions. Over the past 9 years, Dr. Businelle (MPI) has led the development of the InsightTM mHealth Platform. This platform enables researchers to rapidly create innovative smartphone-based studies that include EMA and just-in-time adaptive interventions (JITAI) in a matter of weeks. The platform has supported 113 research studies to date (60 of these studies received funding from the NIH). The InsightTM platform was used to create the Smart Treatment (Smart-T) suite of apps, including the Smart-T Alcohol app that we tested in our recently completed NIAAA-funded R34 study. All participants will receive a version of the InsightTM app (UC or Smart-T Alcohol) on their personal phone or a study phone that is loaned to them.
Usual Care (UC). We will carefully document engagement with AUD treatments (shelter and non-shelter based) via EMA each day for examination in exploratory moderator analyses (Aim 3). All participants at the recruitment sites have access to 12-step support groups (e.g., Alcoholics Anonymous), intensive or supportive outpatient services, and medical and/or psychiatric care. Though initially conceived as part of the Smart-T Alcohol intervention, for ethical reasons individuals in either group who report heavy drinking episode(s) will receive feedback about the negative health effects of heavy drinking and those who report high-intensity drinking (i.e., Women: 8 drinks/day; Men: 10 drinks/day) will be immediately referred for additional treatment services via a designated shelter referral/contact (i.e., shelter contacts will receive encrypted emails that state when study participants report high-intensity drinking). All five shelters conduct a needs assessment as part of their intake process. Access to supportive services (e.g., computer access, laundry facilities, physical and mental healthcare) are also provided as part of standard shelter services either in-house or through partnerships with local organizations.
Usual Care + Smart-T Alcohol. Participants in this condition will receive UC and gain access to the Smart-T Alcohol intervention, which includes two core components: 1) an on-demand "Tips" function/button; and 2) an algorithm that uses EMA responses to assess current risk for alcohol use and automatically delivers tailored messages to help participants achieve their daily drinking goal (i.e., stay sober, cut down on drinking, no drinking goal). On days when there is an abstinence or reduction goal, the app will provide tailored treatment messages that aim to help participants achieve their chosen goal. On days when there is no drinking goal, the app's gain-framed messages will focus on increasing motivation to set a reduction or abstinence goal. The app has been customized using iterative, user-centered design procedures to increase clarity and helpfulness of messages and ensure app usability in this population.
Study Type
Enrollment (Estimated)
Phase
- Phase 2
- Phase 3
Contacts and Locations
Study Contact
- Name: Krista Kezbers, PhD
- Phone Number: 45042 405-271-8001
- Email: krista-kezbers@ouhsc.edu
Study Contact Backup
- Name: Michael Businelle, PhD
- Phone Number: 50460 405-271-8001
- Email: michael-businelle@ouhsc.edu
Study Locations
-
-
Oklahoma
-
Oklahoma City, Oklahoma, United States, 73104
- Recruiting
- University of Oklahoma Health Sciences Center
-
Contact:
- Michael S Businelle, PhD
- Phone Number: 50460 405-271-8001
- Email: michael-businelle@ouhsc.edu
-
Contact:
- Krista Kezbers, PhD
- Phone Number: 45042 405-271-8001
- Email: krista-kezbers@ouhsc.edu
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- At least 18 years old
- 8 or above on the AUDIT
- Receiving shelter-based services
- Consuming 1 or more standard drink of alcohol in the past week
- Score of 4 or higher on the REALM-SF
- Score under 8 on the 6CIT
Exclusion Criteria:
- Under 18 years old
- Not meeting other inclusion criteria
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Usual Care (UC)
All participants at the recruitment sites have access to 12-step support groups, intensive or supportive outpatient services, and/or medical and/or psychiatric care.
All participants that report heavy drinking episode(s) during daily smartphone-based surveys will be referred for additional treatment services via a designated shelter referral/contact.
|
Participants will receive standard shelter-based treatment (Usual Care) along with completing surveys and assessments.
|
|
Experimental: Usual Care + Smart-T Alcohol
The Smart-T Alcohol arm will receive Usual Care plus the Smart-T Alcohol smartphone-based intervention which includes two core components: 1) an on-demand "Tips" function/button; and 2) an algorithm that uses daily survey responses to assess current risk for alcohol use and automatically delivers tailored messages to help participants achieve their daily drinking goal.
|
Participants will receive standard shelter-based treatment (Usual Care) along with completing surveys and assessments.
The Smart-T Alcohol intervention offers on-demand content and automated contextually tailored messages to reduce alcohol consumption.
The intervention period will span eight-weeks (i.e., weeks 2-9), with follow-up assessments occurring at weeks 9, 13, and 26.
All participants will complete brief daily smartphone-based surveys for 13 weeks.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of drinks per week
Time Frame: 13 weeks
|
The number of drinks per week reported during daily EMAs.
|
13 weeks
|
|
Number of heavy drinking days
Time Frame: 13 weeks
|
Number of heavy drinking days reported in daily EMAs (defined in alignment with NIAAA guidelines as ≥ 5 drinks/day for men and ≥ 4 drinks/day for women).
|
13 weeks
|
|
Total number of drinking days
Time Frame: 13 weeks
|
The total number of drinking days will be calculated using EMA data.
|
13 weeks
|
|
Slopes of key drinking factors over time(e.g., urge, mood, alcohol availability, motivation)
Time Frame: 13 weeks
|
Analyses will determine the effects of tailored intervention messages (Smart-T app group) versus no intervention messages (Usual Care) on key drinking risk factors over time.
|
13 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of drinks per week
Time Frame: 13 weeks
|
The number of drinks per week will be calculated using timeline follow-back data.
|
13 weeks
|
|
Number of heavy drinking days
Time Frame: 13 weeks
|
The number of heavy drinking days will be calculated using timeline follow-back data.
|
13 weeks
|
|
Total number of drinking days
Time Frame: 13 weeks
|
The total number of drinking days will be calculated using timeline follow-back data.
|
13 weeks
|
|
Alcohol-related problems
Time Frame: End of treatment and each follow-up assessment (i.e., 9, 13, and 26 weeks).
|
Total scores on the end of treatment Short Inventory of Problems (SIP) measure controlling for baseline SIP scores.
|
End of treatment and each follow-up assessment (i.e., 9, 13, and 26 weeks).
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 17400
- R01AA031280 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Alcohol Misuse
-
University of BirminghamNewcastle University; National Institute for Health Research, United Kingdom; University of York and other collaboratorsUnknownAlcohol Misuse | Drug Misuse
-
University of California, San FranciscoNational Institute on Alcohol Abuse and Alcoholism (NIAAA)Not yet recruiting
-
OmniSolutions Laboratory Holdings LimitedCompletedAlcohol Misuse | Alcohol HangoverChina
-
University of ReginaSaskatchewan Health Research Foundation; Saskatchewan Centre for Patient-Oriented... and other collaboratorsCompleted
-
mHealth Systems Inc.Boston Children's Hospital; University of North Carolina, CharlotteRecruitingAlcohol Misuse | Cannabis MisuseUnited States
-
Faith Summersett WilliamsNot yet recruiting
-
Pacific Institute for Research and EvaluationCompleted
-
Syracuse VA Medical CenterNational Institute on Alcohol Abuse and Alcoholism (NIAAA)Not yet recruiting
-
University of ReginaSaskatchewan Health Research Foundation; Saskatchewan Centre for Patient-Oriented...Completed
-
Brigham and Women's HospitalCompletedAlcohol MisuseUnited States
Clinical Trials on Usual Care
-
Charite University, Berlin, GermanyCompletedMultiple Sclerosis | FatigueGermany
-
Charite University, Berlin, GermanyMammazentrum Hamburg am Krankenhaus Jerusalem, Germany; Dorit und Alexander...Completed
-
European Institute for Evidence Based Osteopathic...Unknown
-
Suzanna ZickUniversity of MichiganTerminatedQuality of Life | Fatigue | Lupus Erythematosus, Systemic | Sleep | Pain, ChronicUnited States
-
Centers for Disease Control and PreventionCompleted
-
University Hospital, MontpellierCompletedOsteoarthritis | Mindfulness | MBSRFrance
-
Gachon University Gil Oriental Medical HospitalKorea Health Industry Development InstituteCompletedKnee Replacement | AcupunctureKorea, Republic of
-
Mayo ClinicCompleted
-
Parc de Salut MarCompleted
-
The Miriam HospitalNational Institute on Aging (NIA)CompletedHeart FailureUnited States